Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Evan Y. Yu"'
Autor:
Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu, Nobuaki Matsubara, Lajos Géczi, Susanna Y-S Cheng, Yves Fradet, Stephane Oudard, Christof Vulsteke, Rafael Morales Barrera, Aude Fléchon, Seyda Gunduz, Yohann Loriot, Alejo Rodriguez-Vida, Ronac Mamtani, Evan Y Yu, Kijoeng Nam, Kentaro Imai, Blanca Homet Moreno, Ajjai Alva, Diana Vera Cascallar, Mirta Varela, Mauricio Fernandez Lazzaro, Diego Lucas Kaen, Gabriela Gatica, David Hugo Flores, Agustin Falco, Matias Molina, Filip Van Aelst, Brieuc Sautois, Jean-Pascal Machiels, Denis Schallier, Leandro Brust, Liane Rapatoni, Sergio J Azevedo, Gisele Marinho, Joao Paulo Holanda Soares, Carlos Dzik, Jamile Almeida Silva, Andre Poisl Fay, Joel Gingerich, Cristiano Ferrario, Kylea Potvin, Marie Vanhuyse, Mahmoud Abdelsalam, Susanna Cheng, Christian Caglevic, Felipe Reyes, Jose Luis Leal, Francisco Francisco, Carolina Ibanez, Florence Joly, Brigitte Laguerre, Sylvain Ladoire, Aude Flechon, Delphine Topart, Olivier Huillard, Stéphane Oudard, Marine Gross-Goupil, Stephane Culine, Gwenaelle Gravis, Peter Reichardt, Margitta Retz, Jan Herden, David Pfister, Carsten Ohlman, Michael Stoeckle, Manfred Wirth, Anja Lorch, Guenter Niegisch, Peter J Goebell, Martin Boegemann, Axel Merseburger, Georgios Gakis, Jens Bedke, Andreas Neisius, Christian Thomas, Thomas Hoefner, Andras Telekes, Judit Erzsebet Kosa, Janos Revesz, Gyorgy Bodoky, Tibor Csoszi, Andras Csejtei, Lajos Geczi, Agnes Ruzsa, Zsuzsanna Kolonics, Jozsef Erfan, Ray McDermott, Richard Bambury, Avishay Sella, Stephen Jay Frank, Daniel Kejzman, Olesya Goldman, Eli Rosenbaum, Avivit Peer, Raanan Berger, Keren Rouvinov, David Sarid, Satoshi Fukasawa, Gaku Arai, Akito Yamaguchi, Akira Yokomizo, Tatsuya Takayama, Hidefumi Kinoshita, Eiji Kikuchi, Ryuichi Mizuno, Yasuhisa Fujii, Naoto Sassa, Yoshihisa Matsukawa, Kiyohide Fujimoto, Toshiki Tanikawa, Yoshihiko Tomita, Kazuo Nishimura, Masao Tsujihata, Masafumi Oyama, Naoya Masumori, Hiroomi Kanayama, Toshimi Takano, Yuji Miura, Jun Miyazaki, Akira Joraku, Tomokazu Kimura, Yoshiaki Yamamoto, Kazuki Kobayashi, Ronald De Wit, Maureen Aarts, Winald Gerritsen, Maartje Los, Laurens Beerepoot, Adel Izmailov, Sergey Igorevich Gorelov, Boris Yakovlevich Alekseev, Andrey Semenov, Vladimir Anatolyevich Kostorov, Sergey M Alekseev, Alexander Zyryanov, Vasiliy Nikolaevich Oschepkov, Vladimir Aleksandrovich Shidin, Vladimir Ivanovich Vladimirov, Rustem Airatovich Gafanov, Petr Alexandrovich Karlov, David Brian Anderson, Lucinda Shepherd, Graham Lawrence Cohen, Bernardo Louis Rapoport, Paul Ruff, Nari Lee, Woo Kyun Bae, Hyo Jin Lee, Urbano Anido Herranz, Enrique Grande, Teresa Alonso Gordoa, Josep Guma Padro, Daniel Castellano Gauna, Jose Angel Arranz, Jose Munoz Langa, Regina Girones Sarrio, Alvaro Montesa Pino, Maria Jose Juan Fita, Yu-Li Su, Yung-Chang Lin, Wen-Pin Su, Ying-Chun Shen, Yen-Hwa Chang, Yi-Hsiu Huang, Virote Sriuranpong, Phichai Chansriwong, Vichien Srimuninnimit, Pongwut Danchaivijitr, Huseyin Abali, Sinan Yavuz, Ozgur Ozyilkan, Mehmet Ali Nahit Sendur, Meltem Ekenel, Mustafa Ozguroglu, Cagatay Arslan, Mustafa Ozdogan, Alison Birtle, Robert Huddart, Maria de Santis, Anjali Zarkar, Linda Evans, Syed Hussain, Christopher DiSimone, Antonio F Muina, Peter Schlegel, Haresh S Jhangiani, Michael Harrison, Dennis E Slater, David Wright, Ivor J Percent, Jianqing Lin, Clara Hwang, Sumati Gupta, Madhuri Bajaj, Robert Galamaga, John Eklund, James Wallace, Mikhail Shtivelband, Jason Jung-Gon Suh, Nafisa Burhani, Matthew Eadens, Krishna Gunturu, Earle Burgess, John Wong, Arvind Chaudhry, Peter Van Veldhuizen, Stephanie Graff, Christian A Thomas, Ian D Schnadig, Benedito Carneiro, Maha Hussain, Alicia Morgans, John T Fitzharris, Ira A Oliff, Jacqueline Vuky, Ralph Hauke, Ari Baron, Monika Joshi, Britt H Bolemon, Peter Jiang, Anthony E Mega, Maurice Markus, Nicklas Pfanzelter, William Eyre Lawler, Patrick Wayne Cobb, Jay G Courtright, Sharad Jain, Gurjyot Doshi, Vijay K Gunuganti, Oliver Alton Sartor, Scott W Cole, Hani Babiker, Edward M Uchio, Alexandra Drakaki, Heather D Mannuel, Elizabeth Guancial, Chunkit Fung, Anthony Charles, Robert J Amato, Yull Arriaga, Isaac Bowman, Steven Ades, Robert Dreicer, Evan Yu, David I Quinn, Mark Fleming
Publikováno v:
The lancet oncology
The Lancet. Oncology, Vol. 22, no. 7, p. 931-945 (2021)
The Lancet. Oncology, Vol. 22, no. 7, p. 931-945 (2021)
Summary Background PD-1 and PD-L1 inhibitors are active in metastatic urothelial carcinoma, but positive randomised data supporting their use as a first-line treatment are lacking. In this study we assessed outcomes with first-line pembrolizumab alon
Autor:
Sarah M H, Einerhand, Anna J, Black, Homayoun, Zargar, Adrian S, Fairey, Colin P, Dinney, Maria C, Mir, Laura-Maria, Krabbe, Michael S, Cookson, Niels-Erik, Jacobson, Jeffrey S, Montgomery, Nikhil, Vasdev, Evan Y, Yu, Evanguelos, Xylinas, Wassim, Kassouf, Marc A, Dall'Era, Srikala S, Sridhar, Jonathan S, McGrath, Jonathan, Aning, Shahrokh F, Shariat, Jonathan L, Wright, Andrew C, Thorpe, Todd M, Morgan, Jeff M, Holzbeierlein, Trinity J, Bivalacqua, Scott, North, Daniel A, Barocas, Yair, Lotan, Petros, Grivas, Jorge A, Garcia, Andrew J, Stephenson, Jay B, Shah, Siamak, Daneshmand, Kamran, Zargar-Shoshtari, Philippe E, Spiess, Bas W G, van Rhijn, Peter C, Black, Laura S, Mertens
Publikováno v:
World journal of urology. 40(11)
Cisplatin-based chemotherapy followed by radical cystectomy (RC) is recommended in patients with muscle-invasive bladder cancer (MIBC). However, up to 50% of patients are cisplatin ineligible. The aim of this study was to compare clinical outcomes af
Autor:
Anthea Phuong, J. Peter Marquardt, Ryan O'Malley, Sarah K. Holt, Grace Laidlaw, Zachary Eagle, Steven Ngo, Delaney Orcutt, George R. Schade, Daniel W. Lin, Michael T. Schweizer, Todd Yezefski, Evan Y. Yu, Bruce Montgomery, Petros Grivas, Florian J. Fintelmann, Sarah P. Psutka
Publikováno v:
Urologic oncology. 40(10)
To quantify changes in body composition during cytotoxic chemotherapy for germ cell carcinoma of the testis (GCT) and evaluate associations between change in skeletal muscle and adipose tissue and chemotherapy-associated adverse events.This retrospec
Publikováno v:
American Society of Clinical Oncology Educational Book. :262-275
Diagnostic and therapeutic challenges in the field of bladder and upper tract cancers provide opportunities for multidisciplinary care. Urothelial cancers make up the majority of the histologic subtype of bladder and upper tract cancers. Although the
Autor:
Sarah K. Holt, Jorge Ramos, John L. Gore, Matthew D. Galsky, George R. Schade, Jonathan L. Wright, Evan Y. Yu
Publikováno v:
BJU Int
OBJECTIVE To assess the association of venous thromboembolism (VTE) with different chemotherapy regimens in patients with urothelial tract cancer. PATIENTS AND METHODS We identified patients aged ≥66 years, diagnosed with urothelial tract cancer in
Autor:
Elizabeth R. Plimack, Salvatore Lo Vullo, Guru Sonpavde, Ulka N. Vaishampayan, Sandy Srinivas, Matthew D. Galsky, Daniele Raggi, Joaquim Bellmunt, Patrizia Giannatempo, Jonathan E. Rosenberg, Aristotle Bamias, Luigi Mariani, Andrea Necchi, Simon J. Crabb, Evan Y. Yu, Guenter Niegisch, Srikala S. Sridhar, Thomas Powles, Christine Theodore, Dominik Berthold
Publikováno v:
Journal of Urology. 200:1207-1214
We evaluated the impact of the number of cycles of platinum based, first line chemotherapy (fewer than 6 cycles vs the conventional 6 cycles or more) on the survival of patients with metastatic urothelial carcinoma.We used the RISC (Retrospective Int
Autor:
Janet Trowbridge, Peter H. O'Donnell, Arjun Vasant Balar, Joyce Steinberg, Evan Y. Yu, Jae-Lyun Lee, Mark N. Stein, Andrea Necchi, Michael R. Harrison, Daniel P. Petrylak, Shang-Ying Liang, Bradley Alexander McGregor, Se Hoon Park, David I. Quinn, Michiel S. van der Heijden, Mary Campbell, Yohann Loriot, Takahiro Kojima, Jonathan E. Rosenberg, Elisabeth I. Heath
Summary Background Locally advanced or metastatic urothelial carcinoma is generally incurable and has scarce treatment options, especially for cisplatin-ineligible patients previously treated with PD-1 or PD-L1 therapy. Enfortumab vedotin is an antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4439042fdb691a716c5dade5f1b9990
Autor:
Wassim Kassouf, John S. McGrath, Bas W.G. van Rhijn, Jay B. Shah, Marc A. Dall'Era, Andrew J. Stephenson, Shahrokh F. Shariat, Petros Grivas, Srikala S. Sridhar, Paolo Gontero, Philippe E. Spiess, Yair Lotan, Andrew C. Thorpe, Trinity J. Bivalacqua, Adrian Fairey, Jonathan L. Wright, Evan Y. Yu, Michael S. Cookson, Scott North, Todd M. Morgan, Jeffrey M. Holzbeierlein, Francesco Soria, Peter C. Black, Daniel A. Barocas
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Cisplatin-based neoadjuvant chemotherapy (NAC) followed by radical cystectomy (RC) is the standard and recommended treatment for clinical T2-T4aN0M0 bladder cancer. Howev...
Autor:
Olivia A. Do, Tanya B. Dorff, Joaquim Bellmunt, Evan Y. Yu, Aristotelis Bamias, Ulka N. Vaishampayan, Sandy Srinivas, Jorge Ramos, Andrea Necchi, Lorin A. Ferris, Sarah K. Holt, Elizabeth R. Plimack, Jack Baniel, Lauren C. Harshman, Ugo De Giorgi, Sumanta K. Pal, Simon J. Crabb, Sylvain Ladoire, Matthew D. Galsky
Background: Optimal chemotherapy for patients who received cisplatin for localized urothelial carcinoma (UC) and develop metastatic disease is unclear. We compared the efficacy of platinum-based (PBC) versus non–platinum-based (NPBC) first-line che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00bf94447c43a215a33a6e86988a8548
Autor:
Elisabeth I. Heath, Andrea Necchi, Takahiro Kojima, Mark N. Stein, Michiel S. van der Heijden, Janet Trowbridge, Daniel P. Petrylak, Joyce Steinberg, Se Hoon Park, Evan Y. Yu, Yohann Loriot, Bradley Alexander McGregor, Michael R. Harrison, Arjun Vasant Balar, Shang-Ying Liang, Jonathan E. Rosenberg, Jae-Lyun Lee
Publikováno v:
Journal of Clinical Oncology. 39:4524-4524
4524 Background: Cisplatin (cis)-ineligible, platinum-naive patients (pts) with locally advanced or metastatic urothelial carcinoma (la/mUC) who progress on/after anti-PD-1/L1 treatment (tx) have a poor prognosis and few tx options. Enfortumab vedoti